Aptevo Therapeutics Inc (APVO) concluded trading on Wednesday at a closing price of $5.13, with 124.15 million shares of worth about $636.91 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -93.73% during that period and on June 18, 2025 the price saw a gain of about 81.91%. Currently the company’s common shares owned by public are about 0.70M shares, out of which, 0.70M shares are available for trading.
Stock saw a price change of 10.32% in past 5 days and over the past one month there was a price change of -17.26%. Year-to-date (YTD), APVO shares are showing a performance of -94.05% which decreased to -99.10% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.81 but also hit the highest price of $485.37 during that period. The average intraday trading volume for Aptevo Therapeutics Inc shares is 279.57K. The stock is currently trading 5.49% above its 20-day simple moving average (SMA20), while that difference is down -44.20% for SMA50 and it goes to -94.66% lower than SMA200.
Aptevo Therapeutics Inc (NASDAQ: APVO) currently have 0.70M outstanding shares and institutions hold larger chunk of about 0.18% of that.
The stock has a current market capitalization of $3.88M and its 3Y-monthly beta is at 5.73. It has posted earnings per share of -$1769.09 in the same period. It has Quick Ratio of 0.67. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for APVO, volatility over the week remained 39.37% while standing at 17.70% over the month.
Coverage by Piper Jaffray stated Aptevo Therapeutics Inc (APVO) stock as an Overweight in their note to investors on October 05, 2017, suggesting a price target of $6 for the stock.
